Moreover, abnormally high PD-L1 expression on tumor cells in TME mediates tumor immune escape, and the development of anti-PD-1/PD-L1 antibodies has recently become a hot topic in cancer immunotherapy [70]. This evidence concerns the gene CD274 and neoplasm.